864063-55-8Relevant academic research and scientific papers
CYANO-PYRIMIDINE INHIBITORS OF EGFR/HER2
-
Page/Page column 67-68, (2021/07/17)
Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with EGFR and/or HER2 activity.
NOVEL AMIDE AND AMIDINE DERIVATIVES AND USES THEREOF
-
Page/Page column 33, (2010/11/03)
The present invention relates to inhibitors of 11-β-hydroxysteroid dehydrogenase type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.
BICYCLO DERIVATIVE
-
Page/Page column 8, (2008/06/13)
A novel bicyclo derivative represented by the following general formula (1), or a pharmaceutically acceptable salt thereof, acts as an effective DPP-IV inhibitor: One example is (2S,4S)-1-[[N-(4-methylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidi
